Sandy Spring Bank’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History
Bought
Maintained
Sold
Other funds holding VAXX
SWM
XT
CGL
GT
FDCDDQ
RF
Sandy Spring Bank's VAXX Position: Q2 2024 in Review
Sandy Spring Bank sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 100 shares — an estimated $72 sold.
Sandy Spring Bank first reported a position in VAXX in Q4 2021 and held it in 7 quarters. The position peaked at $1K in Q4 2021. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.
- Sandy Spring Bank reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
- Sandy Spring Bank sold 100 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $72.
- Sandy Spring Bank first reported a position in Vaxxinity, Inc. Class A Common Stock in Q4 2021 and held it in 7 quarters.
- Sandy Spring Bank's Vaxxinity, Inc. Class A Common Stock position peaked at $1K in Q4 2021.
- 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.
Based on Sandy Spring Bank's 13F filing for Q2 2024, filed 6 Aug 2024.